Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allelotype of neuroblastoma

J Takita1, Y Hayashi, T Kohno

  • 1Biology Division, National Cancer Center Research Institute, Tokyo, Japan.

Oncogene
|November 2, 1995
PubMed
Summary

This study reveals frequent loss of heterozygosity (LOH) on chromosomes 2q, 9p, and 18q in neuroblastoma, beyond previously known sites. LOH on chromosome 9p is linked to advanced disease and poorer prognosis in neuroblastoma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.

Leukemia·2016
Same author

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis.

Oncogene·2016
Same author

ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN.

Oncogene·2016
Same author

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis.

Oncogene·2015
Same author

Systemic lupus erythematosus complicated with liver cirrhosis in a patient with Papillon-Lefèvre syndrome.

Lupus·2014
Same author

Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.

Leukemia·2014

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Loss of heterozygosity (LOH) is implicated in neuroblastoma development, with prior studies focusing on chromosomes 1p, 11q, and 14q.
  • The full spectrum of chromosomal arms affected by LOH in neuroblastoma remains incompletely understood.

Purpose of the Study:

  • To comprehensively screen for LOH across all autosomes and chromosome X in neuroblastoma tumors.
  • To identify novel chromosomal regions and potential tumor suppressor genes involved in neuroblastoma pathogenesis and progression.

Main Methods:

  • Screening of 81 neuroblastoma tumor cases for LOH.
  • Utilized 35 restriction fragment length polymorphism (RFLP) markers and 8 microsatellite markers.
  • Analysis covered all 22 autosomes and chromosome X.

Related Experiment Videos

Main Results:

  • High incidence of LOH (>20%) detected on chromosome arms 1p (26%), 2q (30%), 9p (36%), 11q (24%), 14q (22%), and 18q (31%).
  • LOH on chromosome 9p showed a significant association with advanced disease stage and poor prognosis, independent of N-myc amplification.
  • LOH on other examined chromosomes did not correlate with stage, prognosis, or N-myc amplification.

Conclusions:

  • LOH occurs frequently on chromosomes 2q, 9p, and 18q in neuroblastoma, in addition to 1p, 11q, and 14q.
  • These findings suggest the involvement of multiple tumor suppressor genes in neuroblastoma development.
  • A potential novel tumor suppressor gene on chromosome 9p may play a role in neuroblastoma progression.